Changeflow GovPing Courts & Legal Wilson Asks FDA to Add Cychlorphine to List of ...
Priority review Notice Added Final

Wilson Asks FDA to Add Cychlorphine to List of Controlled Substances

Favicon for www.scag.gov AG: South Carolina News
Published
Detected
Email

Summary

South Carolina Attorney General Alan Wilson sent a letter on April 23, 2026, to FDA Commissioner Martin Makary urging the agency to place the synthetic opioid cychlorphine on the federal schedule of controlled substances. The letter cites one confirmed death in South Carolina and more than 40 deaths in Tennessee linked to the drug. Wilson argues that scheduling would strengthen law enforcement and prosecutorial tools against traffickers and enable public health agencies to issue guidance and track usage patterns. The FDA has not yet acted on the request.

Published by SC-AG on scag.gov . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

About this source

GovPing monitors AG: South Carolina News for new courts & legal regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 49 changes logged to date.

What changed

South Carolina Attorney General Alan Wilson submitted a letter to FDA Commissioner Martin Makary on April 23, 2026, requesting that the agency initiate the process to schedule cychlorphine as a controlled substance under the Controlled Substances Act. The letter details that cychlorphine, a new synthetic opioid, has been linked to at least one death in South Carolina and more than 40 deaths in neighboring Tennessee, with early reports suggesting extreme potency and rapid onset potentially exceeding fentanyl.\n\nAffected parties — including law enforcement agencies, prosecutors, and public health authorities — should monitor whether the FDA acts on this petition. If the FDA initiates scheduling proceedings, manufacturers, distributors, importers, and traffickers of cychlorphine would face criminal and civil penalties under the CSA. Until formal scheduling occurs, no new federal compliance obligations are triggered by this letter alone.

Archived snapshot

Apr 24, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

APR 23, 2026

Attorney General Alan Wilson asks FDA to take action on dangerous new synthetic drug

(COLUMBIA, S.C.) – South Carolina Attorney General Alan Wilson today sent a letter to the head of the U.S. Food and Drug Administration (FDA) asking for it to add the dangerous new drug cychlorphine to the list of controlled substances.

In a letter to FDA Commissioner Martin Makary, Attorney General Wilson wrote that cychlorphine, a new synthetic opioid, is responsible for one confirmed death in South Carolina and more than 40 in our neighboring state of Tennessee.

“Early reports indicate that cychlorphine possesses extreme potency, rapid onset, and could be significantly more deadly than fentanyl. Given these characteristics, I urge the FDA to move swiftly toward the appropriate scheduling of this substance under the Controlled Substances Act,” Attorney General Wilson wrote.

His letter says that adding cychlorphine to the list of controlled substances would improve law enforcement agencies’ and prosecutors’ ability to make cases against people who traffic, distribute, or make the drug. He also wrote that scheduling the drug will protect the community by enabling public health agencies to issue guidance, track emerging patterns of the drug’s spread and use, and coordinate responses before widespread harm occurs.

“Our communities are continually facing the devastating consequences of synthetic opioid misuse. These drugs, often manufactured in China, are being distributed by cartels that do not care who they kill in their illegal efforts to turn a profit. Taking proactive regulatory action on cychlorphine now would represent a meaningful step toward preventing another wave of avoidable loss and give prosecutors the tools they need to hold these traffickers accountable,” he wrote.

You can read the letter here.

Back to News

Media Contact

For media inquiries please contact Robert Kittle, [email protected] or 803-734-3670

Media Contact

Get daily alerts for AG: South Carolina News

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from SC-AG.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
SC-AG
Published
April 23rd, 2026
Instrument
Notice
Branch
Executive
Legal weight
Non-binding
Stage
Final
Change scope
Minor

Who this affects

Applies to
Law enforcement Healthcare providers Drug manufacturers
Industry sector
3254 Pharmaceutical Manufacturing
Activity scope
Drug scheduling petition Synthetic opioid regulation Law enforcement coordination
Geographic scope
United States US

Taxonomy

Primary area
Pharmaceuticals
Operational domain
Regulatory Affairs
Compliance frameworks
GxP
Topics
Public Health Criminal Justice

Get alerts for this source

We'll email you when AG: South Carolina News publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!